Volume 10,Issue 1
Fall 2025
Risk Factors Associated with Colistin-Resistant Acinetobacter baumannii Infection
Acinetobacter baumannii is an important cause of healthcare-associated infections and is resistant to almost all antimicrobial agents, with strains recently reported to be resistant to colistin. In this study, we aimed to identify the risk factors associated with colistin-resistant A. baumannii infections by comparing colistin-resistant and -susceptible A. baumannii isolates. We retrospectively reviewed the medical records of 51 and 100 cases in which colistin-resistant and -susceptible A. baumannii were isolated, respectively. Univariate analysis showed that compared with patients with colistin-sensitive infections, patients with colistin-resistant A. baumannii infections had a combined pulmonary disease (P = 0.017), were admitted to intensive care unit (P = 0.020), and had prior mechanical ventilation (P = 0.003), tracheostomy (P = 0.043), percutaneous drainage (P = 0.070), hemodialysis (P = 0.002); use of colistin (P = 0.000), carbapenem (P = 0.000), and teicoplanin (P = 0.004); and co-infection (P = 0.035). Multivariate analysis indicated that eight variables were related to the likelihood of colistin-resistant A. baumannii infections: use of teicoplanin (odds ratio [OR]: 3.140, 95% confidence interval [CI]: 0.529–18.650), prior hemodialysis (OR: 2.722, 95% CI: 0.851–8.709), combined pulmonary disease (OR: 2.286, 95% CI: 0.998–5.283), prior use of carbapenem (OR: 0.199, 95% CI: 0.863–5.603), co-infection (OR: 1.706, 95% CI: 0.746–3.898), prior mechanical ventilation (OR: 1.614, 95% CI, 0.684– 3.809), intensive care unit admission (OR: 1.387, 95% CI: 0.560–3.435), and prior tracheostomy (OR: 1.102, 95% CI: 0.344–3.527); however, no statistical differences were observed. Although colistin use could not be proven in multivariate analysis, the possibility of being a risk factor cannot be ruled out.
1. Moubareck CA, Halat DH. Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics (Basel). 2020;9:119.
2. National Antimicrobial Resistance Surveillance in Korea 2020 Annual Report. Division of Antimicrobial Resistance Control, Korea Disease Control and Prevention Agency. 2021;Cheongju:125–126.
3. Karakonstantis S, Kritsotakis EI, Gikas A. Pandrug-Resistant Gram-Negative Bacteria: A Systematic Review of Current Epidemiology, Prognosis and Treatment Options. J Antimicrob Chemother. 2020;75:271–282.
4. Biswas S, Brunel JM, Dubus JC, et al. Colistin: An Update on the Antibiotic of the 21st Century. Expert Rev Anti Infect Ther. 2012;10:917–934.
5. Pormohammad A, Mehdinejadiani K, Gholizadeh P, et al. Global Prevalence of Colistin Resistance in Clinical Isolates of Acinetobacter baumannii: A Systematic Review and Meta-Analysis. Microb Pathog. 2020;139:103887.
6. Novovic K, Jovcic B. Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology. Antibiotics (Basel). 2023;12:516.
7. Richter SE, Miller L, Uslan DZ, et al. Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates. J Clin Microbiol. 2018;56:e00149-18.
8. Giamarellou H. Epidemiology of Infections Caused by Polymyxin-Resistant Pathogens. Int J Antimicrob Agents. 2016;48:614–621.
9. van Duin D, Doi Y. Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road? J Clin Microbiol. 2015;53:3116–3117.
10. Mantzarlis K, Makris D, Zakynthinos E. Risk Factors for the First Episode of Acinetobacter baumannii Resistant to Colistin Infection and Outcome in Critically Ill Patients. J Med Microbiol. 2020;69:35–40.
11. Yilmaz GR, Dizbay M, Guven T, et al. Risk Factors for Infection with Colistin-Resistant Gram-Negative Microorganisms: A Multicenter Study. Ann Saudi Med. 2016;36:216–222.
12. Inchai J, Liwsrisakun C, Theerakittikul T, et al. Risk Factors of Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand. J Infect Chemother. 2015;21:570–574.
13. Matthaiou DK, Michalopoulos A, Rafailidis PI, et al. Risk Factors Associated with the Isolation of Colistin-Resistant Gram-Negative Bacteria: A Matched Case-Control Study. Crit Care Med. 2008;36:807–811.
14. Elham B, Fawzia A. Colistin Resistance in Acinetobacter baumannii Isolated from Critically Ill Patients: Clinical Characteristics, Antimicrobial Susceptibility and Outcome. Afr Health Sci. 2019;19:2400–2406.